VIA NOVA THERAPEUTICS
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections for which current treatments are lacking or inadequate. The current programs were part of an antiviral portfolio led by the founders while at Novartis and target several important respiratory viruses (including influenza viruses, adenoviruses, and rhinoviruses) as well as human polyomaviruses, which produce severe disease in immunocompromised hosts. The company targets fundamental mechanisms of viral replication and accordingly can support discovery of novel therapeutics for other viral infections as well.
VIA NOVA THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Oakland, California, United States
Country:
United States
Website Url:
http://www.vianovatx.com
Total Employee:
1+
Status:
Active
Contact:
510-227-2102
Total Funding:
25 M USD
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Bilayer Therapeutics
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Aditum Bio
Aditum Bio investment in Series A - Via Nova Therapeutics
Official Site Inspections
http://www.vianovatx.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Via Nova Therapeutics"
HOME | Via Nova Therapeutics | Novel Therapies for Viral Diseases
Via Nova Therapeutics is committed to discovering novel therapies for viral diseases, especially those arising from acute & subacute infections, and to pioneer sustainable business strategies โฆSee details»
About Us | Via Nova Therapeutics | Novel Therapies for โฆ
For the past two decades, industry has focused most of its antiviral efforts on the major chronic viral diseases: HIV, HBV, and HCV. At Via Nova, we believe that the next frontier of unmet medical need in virology exists among the acute and โฆSee details»
Our Team | Via Nova Therapeutics | Novel Therapies โฆ
The Via Nova Leadership and Board of Directors are veteran drug discovery and development teams with decades of combined anti-infective experience.See details»
Via Nova Therapeutics - Crunchbase Company Profile & Funding
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections. View contacts for Via Nova Therapeutics to access new leads and connect with โฆSee details»
Via Nova Therapeutics | LinkedIn
Via Nova Therapeuticsโ mission is to discover and develop safe and effective new therapies for acute and subacute viral diseases for which current treatments are lacking or inadequate. We โฆSee details»
Via Nova Therapeutics - Berkeley Startup Cluster
Via Nova Therapeutics deploys state-of-the-art drug discovery modalities to identify novel, first-in-class antivirals for the individual infections they study.See details»
Via Nova Therapeutics Announces FDA clearance of โฆ
OAKLAND, Calif., Sept. 21, 2023 /PRNewswire/ -- Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat viral infections with โฆSee details»
Via Nova Therapeutics Announces FDA clearance of โฆ
OAKLAND, CA โ 21 September 2023 โ Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat viral infections with significant โฆSee details»
Via Nova Therapeutics Announces FDA Clearance of โฆ
These programs target acute viral respiratory and ocular infections, and infections of the immune compromised. For more information about our people, science, and pipeline, please visit www.vianovatx.com.See details»
Via Nova Therapeutics - Overview, News & Similar companies
Sep 21, 2023ย ยท View Via Nova Therapeutics (www.vianovatx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Via Nova Therapeutics - Craft
See insights on Via Nova Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Via Nova Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
OAKLAND, Calif., Sept. 21, 2023 /PRNewswire/ -- Via Nova Therapeutics, Inc., a biotechnology company focused on discovering and developing therapeutics to treat viral infections with โฆSee details»
Via Nova Therapeutics, Inc. (Via Nova Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
About Via Nova Therapeutics Via Nova's mission is to discover and develop safe and effective new therapies for viral diseases for which current treatments are lacking or inadequate.See details»
Via Nova Therapeutics Announces $20 Million Series A Financing โฆ
OAKLAND, Calif., Sept. 7, 2021 /PRNewswire/ -- Via Nova Therapeutics announced today that it has closed its Series A financing and raised $20 million from Aditum Bio to advance the โฆSee details»
Via Nova Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Via Nova Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Latest News | Via Nova Therapeutics
Sep 21, 2023ย ยท Via Nova's mission is to discover and develop safe and effective new therapies for viral diseases for which current treatments are lacking or inadequate. Founded in August of โฆSee details»
Via Nova Therapeutics - VentureRadar
Website: https://vianovatx.com/ Develops therapeutics for acute and subacute viral infections with inadequate treatments, targeting respiratory viruses, polyomaviruses, and viral replication โฆSee details»
Via Nova Therapeutics Announces FDA clearance of โฆ
Sep 22, 2023ย ยท These programs target acute viral respiratory and ocular infections, and infections of the immune compromised. For more information about our people, science, and pipeline, โฆSee details»
Organisation vs. Organization: Whatโs the Difference?
In this article, Iโll compare organisation vs. organization. Iโll use each one in a sentence. Then, Iโll give you a helpful trick to remember whether to use organisation or organization in your โฆSee details»
Our Pipeline | Via Nova Therapeutics | Novel Therapies for Viral โฆ
Small molecule inhibitor for the treatment of ocular infections in otherwise healthy individuals and severe systemic infections in immunocompromised patients. Our foundation is built on a โฆSee details»